Pharmalink Healthcare

Pimapexole 1 (Pramipexole Tablets BP 1.0 mg) is a dopamine agonist medication manufactured by Steris Healthcare, primarily indicated for the treatment of Parkinson’s disease and moderate to severe primary restless legs syndrome (RLS). Each tablet contains 1.0 mg of Pramipexole dihydrochloride, which stimulates dopamine receptors in the brain to improve motor control, reduce tremors, and alleviate stiffness.

Pimapexole 1 helps restore normal movement and coordination by mimicking the action of dopamine, a neurotransmitter that becomes deficient in Parkinson’s disease. It provides significant symptomatic relief and enhances mobility, particularly in early and advanced stages of the condition, either as monotherapy or in combination with levodopa.

The medication is rapidly absorbed after oral administration and can be taken with or without food, as directed by a physician. It exhibits dose-dependent pharmacokinetics with a half-life of approximately 8–12 hours, allowing for once or twice daily dosing. Mild side effects such as nausea, dizziness, or somnolence may occur initially but usually improve with continued therapy. Manufactured under GMP-certified facilities by Steris Healthcare, Pimapexole 1 ensures consistent quality, safety, and therapeutic reliability.